Bill Text: HI SB3094 | 2018 | Regular Session | Introduced
Bill Title: Relating To Prescription Drugs Containing Cannabidiol.
Spectrum: Partisan Bill (Democrat 8-0)
Status: (Introduced - Dead) 2018-02-22 - The committee on CPH deferred the measure. [SB3094 Detail]
Download: Hawaii-2018-SB3094-Introduced.html
|
THE SENATE |
S.B. NO. |
3094 |
|
TWENTY-NINTH LEGISLATURE, 2018 |
|
|
|
STATE OF HAWAII |
|
|
|
|
|
|
|
|
||
|
|
||
A BILL FOR AN ACT
relating to prescription drugs containing cannabidiol.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:
SECTION 1. Chapter 329, Hawaii Revised Statutes, is amended by adding a new section to be appropriately designated and to read as follows:
"§329- Food
and Drug Administration-approved drugs; cannabidiol. (a)
Upon approval by the federal Food and Drug Administration of one or more
prescription drugs containing cannabidiol, the following activities shall be
lawful in the State:
(1) The clinically
appropriate prescription for a patient of a Food and Drug
Administration-approved prescription drug containing cannabidiol by a health
care provider licensed to prescribe medications in this State and acting within
the health care provider's authorized scope of practice;
(2) The dispensing,
pursuant to a valid prescription, of a Food and Drug Administration-approved
prescription drug containing cannabidiol to a patient or a patient's authorized
representative by a pharmacist or another health care provider licensed to
dispense medications in this State and acting within the health care provider's
authorized scope of practice;
(3) The possession
and transportation of a Food and Drug Administration-approved prescription drug
containing cannabidiol by a patient to whom a valid prescription was issued or
by the patient's authorized representative;
(4) The possession
and transportation of a Food and Drug Administration-approved prescription drug
containing cannabidiol by a licensed pharmacy or wholesaler to facilitate the
appropriate dispensing and use of the drug; and
(5) The use of a
Food and Drug Administration-approved prescription drug containing cannabidiol
by a patient to whom a valid prescription was issued; provided that the patient
uses the drug only for legitimate medical purposes in conformity with
instructions from the prescriber and dispenser.
(b) Upon approval by the Food and Drug Administration
of one or more prescription drugs containing cannabidiol, the department shall
amend its rules to conform to the requirements of subsection (a).
(c) Nothing in this section shall be construed to amend, alter, or otherwise restrict access to medical cannabis, recreational marijuana, or both, as authorized under state law."
SECTION 2. New statutory material is underscored.
SECTION 3. This Act shall take effect upon its approval.
|
INTRODUCED BY: |
_____________________________ |
|
|
|
Report Title:
Cannabidiol; Prescription Drugs; Food and Drug Administration
Description:
Specifies certain activities that shall become lawful, upon approval by the federal Food and Drug Administration of one or more prescription drugs containing cannabidiol.
The summary description
of legislation appearing on this page is for informational purposes only and is
not legislation or evidence of legislative intent.
